A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cellsJIANNONG LI; VIALLET, Jean; HAURA, Eric B et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 3, pp 525-534, issn 0344-5704, 10 p.Article

Gene therapy for lung cancerHAURA, Eric B; SOTOMAYOR, Eduardo; ANTONIA, Scott J et al.Molecular biotechnology. 2003, Vol 25, Num 2, pp 139-148, issn 1073-6085, 10 p.Article

Targeting epidermal growth factor receptor: Central signaling kinase in lung cancerYOSHIDA, Takeshi; GUOLIN ZHANG; HAURA, Eric B et al.Biochemical pharmacology. 2010, Vol 80, Num 5, pp 613-623, issn 0006-2952, 11 p.Article

Activated epidermal growth factor receptor-stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancerHAURA, Eric B; ZHONG ZHENG; LANXI SONG et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8288-8294, issn 1078-0432, 7 p.Article

Randomized International Phase III Trial of ERCC1 and RRM1 Expression―Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non―Small-Cell Lung CancerBEPLER, Gerold; WILLIAMS, Charles; CHIAPPORI, Alberto et al.Journal of clinical oncology. 2013, Vol 31, Num 19, pp 2404-2412, issn 0732-183X, 9 p.Article

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancerREMILY-WOOD, Elizabeth R; LIU, Richard Z; LANCET, Jeffrey et al.Proteomics. Clinical applications (Print). 2011, Vol 5, Num 7-8, pp 383-396, issn 1862-8346, 14 p.Article

Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non-Small Cell Lung CancerCHIAPPORI, Alberto A; HAURA, Eric; SIMON, George et al.Clinical cancer research. 2008, Vol 14, Num 5, pp 1464-1469, issn 1078-0432, 6 p.Article

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancerBEPLER, Gerold; SHARMA, Swati; CANTOR, Alan et al.Journal of clinical oncology. 2004, Vol 22, Num 10, pp 1878-1885, issn 0732-183X, 8 p.Article

Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevanceBEPLER, Gerold; ZHONG ZHENG; ROBINSON, Lary et al.Lung cancer. 2005, Vol 47, Num 2, pp 183-192, issn 0169-5002, 10 p.Article

Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisGUILIAN NIU; WRIGHT, Kenneth L; HELLER, Richard et al.Oncogene (Basingstoke). 2002, Vol 21, Num 13, pp 2000-2008, issn 0950-9232Article

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract TumorsGRAY, Jhanelle E; HAURA, Eric; TETTEH, Leticia et al.Clinical cancer research (Print). 2014, Vol 20, Num 6, pp 1644-1655, issn 1078-0432, 12 p.Article

Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell linesDASGUPTA, Piyali; RIZWANI, Wasia; HAURA, Eric et al.International journal of cancer (Print). 2009, Vol 124, Num 1, pp 36-45, issn 0020-7136, 10 p.Article

Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancerHOWARD, Brandon A; ZHONG ZHENG; CAMPA, Michael J et al.Lung cancer. 2004, Vol 46, Num 3, pp 313-323, issn 0169-5002, 11 p.Article

Stakeholder perceptions of thoracic rapid tissue donation: An exploratory studyMCINTYRE, Jessica; PRATT, Christie; PENTZ, Rebecca D et al.Social science & medicine (1982). 2013, Vol 99, pp 35-41, issn 0277-9536, 7 p.Article

Direct repression of the Mcl-1 promoter by E2F1CROXTON, Rhonda; YIHONG MA; LANXI SONG et al.Oncogene (Basingstoke). 2002, Vol 21, Num 9, pp 1359-1369, issn 0950-9232Article

Methods for investigation of targeted kinase inhibitor therapy using chemical proteomics and phosphorylation profilingBIN FANG; HAURA, Eric B; SMALLEY, Keiran S et al.Biochemical pharmacology. 2010, Vol 80, Num 5, pp 739-747, issn 0006-2952, 9 p.Article

Intranuclear Delivery of a Novel Antibody-Derived Radiosensitizer Targeting the DNA-Dependent Protein Kinase Catalytic SubunitHAIRONG XIONG; LEE, Robert J; HAURA, Eric B et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 3, pp 1023-1030, issn 0360-3016, 8 p.Article

Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non-Small Cell Lung CancerCHEN, Dung-Tsa; HSU, Ying-Lin; FULP, William J et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 24, pp 1859-1870, issn 0027-8874, 12 p.Article

Stat3 regulates genes common to both wound healing and cancerDAUER, Daniel J; FERRARO, Bernadette; LANXI SONG et al.Oncogene (Basingstoke). 2005, Vol 24, Num 21, pp 3397-3408, issn 0950-9232, 12 p.Article

Phosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and TumorsYUN BAI; JIANNONG LI; BIN FANG et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 10, pp 2501-2511, issn 0008-5472, 11 p.Article

MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasionJINGCHUNGAO; MCCONNELL, Matthew J; BIN YU et al.International journal of oncology. 2009, Vol 35, Num 2, pp 337-345, issn 1019-6439, 9 p.Article

Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non-Small-Cell Lung CancerHAURA, Eric B; TANVETYANON, Tawee; LANXI SONG et al.Journal of clinical oncology. 2010, Vol 28, Num 8, pp 1387-1394, issn 0732-183X, 8 p.Article

Phase 2 Trial of Docetaxel and Gefitinib in the First-Line Treatment of Patients With Advanced Nonsmall-Cell Lung Cancer (NSCLC) Who Are 70 Years of Age or OlderSIMON, George R; EXTERMANN, Martine; BEPLER, Gerold et al.Cancer. 2008, Vol 112, Num 9, pp 2021-2029, issn 0008-543X, 9 p.Article

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumorsSIMON, George R; ILARIA, Robert L; MILLER, Mary A et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1233-1241, issn 0344-5704, 9 p.Article